STAT

FDA cracks down on ‘vaginal rejuvenation’ devices, citing potential for serious harm

Products being marketed as “vaginal rejuvenation” devices have serious risks and don’t have adequate evidence to support their use for these purposes, the FDA says.
FDA Commissioner Scott Gottlieb

The Food and Drug Administration is cracking down on devices marketed for use in “vaginal rejuvenation.”

In a issued Monday, FDA Commissioner Scott Gottlieb said a growing number of manufacturers are marketing “vaginal rejuvenation”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks